| mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0003 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
| mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.18 |
0.0008 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.001 |
| mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.002 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |